Acceleron Pharma to Present at Piper Jaffray 27th Annual Healthcare Conference

CAMBRIDGE, Mass.--()--Acceleron Pharma Inc. (NASDAQ: XLRN), a clinical stage biopharmaceutical company focused on the discovery, development and commercialization of novel therapeutic candidates that regulate cellular growth and repair, today announced it will present a corporate overview at the Piper Jaffray 27th Annual Healthcare Conference on Tuesday, December 1, 2015 at 3:00 PM EST at The New York Palace Hotel in New York City.

A live audio webcast of the presentation will be available on the “Events and Presentations” page in the Investors & Media section on the Company’s website (www.acceleronpharma.com). A replay of the webcast will also be available from Acceleron’s website.

About Acceleron

Acceleron is a clinical stage biopharmaceutical company focused on the discovery, development and commercialization of novel therapeutic candidates that regulate cellular growth and repair. The company is a leader in understanding the biology of the Transforming Growth Factor-Beta protein superfamily, a large and diverse group of molecules that are key regulators in the growth and repair of tissues throughout the human body, and in targeting these pathways to develop important new medicines. Acceleron has built a highly productive R&D platform that has generated innovative clinical and preclinical therapeutic candidates with novel mechanisms of action. These therapeutic candidates have the potential to significantly improve clinical outcomes for patients with cancer and rare diseases.

For more information, please visit www.acceleronpharma.com.

Contacts

Acceleron Pharma Inc.
Todd James, 617-649-9393
Senior Director, Corporate Communications
or
BMC Communications LLC
Brad Miles, 646-513-3125

Contacts

Acceleron Pharma Inc.
Todd James, 617-649-9393
Senior Director, Corporate Communications
or
BMC Communications LLC
Brad Miles, 646-513-3125